21st European Workshop for Rheumatology Research
- Meeting abstract
In Marseille, Southern France, HLA-B2702 carries higher risk than HLA-B2705 to develop ankylosing spondylitis (AS)
Arthritis Research & Therapy volume 3, Article number: P105 (2001)
HLA-B27 subtypes were defined by molecular typing in 45 patients with AS and 90 controls from Marseille. We subdivided patients and controls in 2 subgroups, according to the birth place of their grandparents: 19 patients and 38 controls constituted the Spanish/North African subgroup; 26 patients and 52 controls constituted the "French" subgroup. In patients from the Spanish/North African subgroup, the frequency of B2702 was higher (74%) than in controls from the same area (21%)pc<0.01 and the frequency of B2705 was lower in patients (25%) than in controls (79%) pc<0.01. In patients from the French group, the frequency of B2702 was higher (7%) than in controls (2%)(N.S.).
Thus, in the population of Southern France, B2702 seems to carry higher risk to develop AS than B2705.
About this article
Cite this article
Guis, S., Nielsen, W., Boetsch, G. et al. In Marseille, Southern France, HLA-B2702 carries higher risk than HLA-B2705 to develop ankylosing spondylitis (AS). Arthritis Res Ther 3, P105 (2001). https://doi.org/10.1186/ar274
- Public Health
- High Risk
- Ankylose Spondylitis
- Molecular Typing